Fortis Malar Hospitals concludes 35th AGM with key resolutions
NiveshIQ
NSE: FORTIS · Healthcare
Fortis Healthcare Ltd.
₹952.05▲ ₹6.60 (+0.70%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on FORTIS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Fortis Healthcare Ltd.
Fortis Healthcare Limited operates as a leading healthcare delivery service provider in India, offering a wide range of services across various specialties including cardiology, critical care, and oncology. The company has reported strong financial performance in FY26, with a 44% surge in profit after tax (PAT) in Q4 and a 31% increase in FY26 profit. Fortis has been expanding its capacity through strategic additions, which has contributed to double-digit revenue and profit growth. The company has also been at the forefront of medical innovation, performing rare surgeries such as robotic fibroid removal. With a strong presence in the Indian healthcare market, Fortis is well-positioned to capitalize on the growing demand for quality healthcare services. The company's focus on preventive hea
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹6,893 Cr +9.40% | ₹7,782 Cr +12.90% | ₹9,128 Cr +17.30% |
| EBITDA Margin | 18.38% | 20.41% | 23.40% |
| Net Profit | ₹645.00 Cr +1.90% | ₹809.00 Cr +25.40% | ₹1,070 Cr +32.30% |
| EPS | ₹7.93 | ₹10.26 | ₹13.80 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Fortis Healthcare Reappoints Dr. Ashutosh Raghuvanshi as MD & CEO Until 2029
Best Healthcare Stocks: Gaurang Shah's Outlook On Apollo Hospitals, Fortis & The Manipal Health IPO
🔒
+ 3 more stories about Fortis Healthcare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹2, 365 Cr, PAT ₹277 Cr, EPS ₹3.52, EBITDA margin 22.7%. Growth context: revenue YoY +17.8%, PAT YoY +47.6%, revenue QoQ +4.4%, PAT QoQ +15.7%. Street verdict: strong miss, revenue surprise -1.6%, PAT surprise -42.6%.
Management's emphasis on new capacity additions and capital expenditure deployment is expected to drive the next phase o...
FY26 (last completed FY): revenue ₹9, 128 Cr, PAT ₹1, 070 Cr, EBITDA margin 23.4%, EPS ₹13.80. Year-on-year: revenue YoY...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for FORTIS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track FORTIS alongside your other holdings
Unlock full FORTIS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Fortis Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Fortis Healthcare Ltd. (FORTIS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Fortis Healthcare Ltd.?
Fortis Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹7,181,916.6L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.